A June 2026 Nature report revealed that mandatory reviews by top officials, checking for a list of 235 disfavored terms, have left hundreds of meritorious NIH applications in administrative limbo (Kozlov, 2026a).
On May 29, 2026, the Office of Management and Budget proposed a rewrite of 2 CFR Part 200, the Uniform Guidance that has governed federal grants management for over a decade.
On June 30, 2026, I sat at a witness table, under oath, in the Rayburn House Office Building in Washington, DC and testified before the House Oversight Committee’s Task Force on the Declassification of Federal Secrets.
For the past eighteen months, the Trump administration’s approach to federal grants has followed a familiar pattern: announce a cancellation, face a lawsuit, sometimes lose.